1. Home
  2. INSP vs NEO Comparison

INSP vs NEO Comparison

Compare INSP & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspire Medical Systems Inc.

INSP

Inspire Medical Systems Inc.

HOLD

Current Price

$43.45

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$13.72

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSP
NEO
Founded
2007
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
INSP
NEO
Price
$43.45
$13.72
Analyst Decision
Buy
Strong Buy
Analyst Count
16
8
Target Price
$94.00
$13.38
AVG Volume (30 Days)
822.0K
2.7M
Earning Date
05-04-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
179.43
N/A
EPS
N/A
N/A
Revenue
$82,050,000.00
N/A
Revenue This Year
$8.02
$10.63
Revenue Next Year
$8.11
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
62.18
N/A
52 Week Low
$38.91
$4.72
52 Week High
$147.03
$13.74

Technical Indicators

Market Signals
Indicator
INSP
NEO
Relative Strength Index (RSI) 49.99 77.68
Support Level $39.26 $11.49
Resistance Level $44.75 $13.74
Average True Range (ATR) 1.99 0.67
MACD 0.49 0.18
Stochastic Oscillator 71.25 95.17

Price Performance

Historical Comparison
INSP
NEO

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: